Press release
Bone Resorption Market Expected to Grow Significantly by 2032: Market Opportunities, Strategic Investments, FDA Approvals | DelveInsight
The bone resorption market is poised for substantial transformation, driven by the rising prevalence of osteoporosis and related disorders, an aging population, and significant advancements in targeted therapies. Key bone resorption companies, including Bioventus, Isto Biologics, Locate Bio, Kuros Biosciences, OssDsign, BONESUPPORT, Cerapedics, DiscGenics, Osteopore, TherageniX, Stryker, DePuy Synthes, Medtronic, Zimmer Biomet, and Orthofix, among others, are innovating in this landscape.DelveInsight's "Bone Resorption - Market Insight, Epidemiology and Market Forecast - 2032 [https://www.delveinsight.com/report-store/bone-resorption-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]" report provides an in-depth understanding of the bone resorption therapeutic market, current treatment practices, and competitive landscape across the United States, EU4 (Germany, Spain, Italy, and France), the UK, and Japan. The report analyzes historical and forecasted bone resorption epidemiological data while delivering crucial insights into emerging therapies, market share of individual treatments, and the evolving competitive landscape in this therapeutic area.
According to the comprehensive analysis, the bone resorption market in the 7MM is projected to experience notable growth during the forecast period (2019-2032), with several pharmaceutical companies actively developing innovative therapeutic approaches to address this significant health challenge.
Download the bone resorption market report to understand which factors are driving the bone resorption therapeutic market @ Bone Resorption Market Trends [https://www.delveinsight.com/sample-request/bone-resorption-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr].
DelveInsight's Epidemiological studies indicate alarming prevalence rates of conditions associated with pathological bone resorption, particularly osteoporosis. In the US alone, approximately 10 million individuals over age 50 are affected by osteoporosis, with projections indicating a 30% increase by 2030.
Gender differences in bone resorption disorders are noteworthy, with the analysis showing osteoporosis being more prevalent among females compared to males. Furthermore, the prevalence increases significantly with age in both genders. These epidemiological patterns highlight the critical need for gender-specific and age-specific approaches in bone resorption management strategies.
Discover evolving trends in the bone resorption patient pool forecasts @ Bone Resorption Epidemiology Analysis [https://www.delveinsight.com/sample-request/bone-resorption-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr].
The current bone resorption treatment landscape encompasses several approaches, including bisphosphonates, selective estrogen receptor modulators, monoclonal antibodies, and hormone-related therapies. DelveInsight's analysis reveals that while existing therapies have established efficacy profiles, significant unmet needs remain, particularly regarding long-term safety, patient compliance, and addressing treatment-resistant cases. The market report provides detailed insights into marketed drugs, their mechanisms of action, and their commercial performance across the 7MM.
The bone resorption pipeline shows promising activity, with numerous therapies at various stages of development. DelveInsight's report highlights emerging drugs in late-stage clinical trials that demonstrate the potential to address current treatment limitations. Key therapies include biosimilars targeting the RANKL pathway, such as RGB-14-P, Bmab 1000, and TVB-009, which are in late-stage trials or nearing approval. Innovative antibody treatments like AGA2118 and SHR-1222, which target sclerostin and DKK1, are also progressing through clinical trials. Research into cathepsin K inhibitors is ongoing, and dual-action agents like romosozumab are already demonstrating real-world benefits. Together, these developments promise more effective and targeted options for managing osteoporosis.
The bone restoration treatment landscape is experiencing some noteworthy developments, particularly with recent FDA approvals and advancements in clinical trials. In March 2025, the FDA approved multiple DENOSUMAB biosimilars, such as BOMYNTRA, OMLYCLO, STOBOCLO, OSENBELT, and CONEXXENCE. Additionally, XBRYK and OSPOMYV received approval in February 2025. These biosimilars have shown equivalent efficacy and safety to the original denosumab in large phase III clinical trials, demonstrating similar improvements in bone mineral density and a reduction in fracture risk.
Discover recent advancements in the bone resorption treatment landscape @ Bone Resorption Recent Developments [https://www.delveinsight.com/sample-request/bone-resorption-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr].
Looking ahead, the bone resorption market is expected to witness significant shifts due to increasing disease awareness, enhanced diagnostic capabilities, and substantial healthcare investments worldwide. Market growth will be further propelled by the aging global population and the rising incidence of associated conditions like osteoporosis. However, challenges remain, including treatment access disparities, reimbursement issues in certain regions, and the need for more personalized therapeutic approaches based on individual patient characteristics and disease manifestations.
DelveInsight's report provides valuable strategic insights for stakeholders navigating this complex landscape, offering a comprehensive analysis of market trends, barriers, opportunities, and the competitive environment. By understanding the current and future dynamics of the bone resorption market, healthcare providers, pharmaceutical companies, and investors can make informed decisions to address the substantial unmet needs in this therapeutic area and improve outcomes for millions affected by pathological bone resorption worldwide.
Table of Contents
1. Key Insights
2. Executive Summary of Bone Resorption
3. Bone Resorption Competitive Intelligence Analysis
4. Bone Resorption: Market Overview at a Glance
5. Bone Resorption: Disease Background and Overview
6. Bone Resorption Patient Journey
7. Bone Resorption Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Bone Resorption Unmet Needs
10. Key Endpoints of Bone Resorption Treatment
11. Bone Resorption Marketed Products
12. Bone Resorption Emerging Therapies
13. Bone Resorption: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Bone Resorption
17. KOL Views
18. Bone Resorption Market Drivers
19. Bone Resorption Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Related Reports
Bone Resorption Pipeline Insight [https://www.delveinsight.com/sample-request/bone-resorption-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]
Bone Resorption Pipeline Insight provides comprehensive insights about the bone resorption pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the bone resorption companies, including Bioventus, Isto Biologics, Locate Bio, Kuros Biosciences, OssDsign, BONESUPPORT, Cerapedics, DiscGenics, Osteopore, TherageniX, Stryker, DePuy Synthes, Medtronic, Zimmer Biomet, and Orthofix, among others.
About DelveInsight
DelveInsight is a leading market research and consulting firm specializing in disease-specific insights and therapeutic market analysis. Their reports integrate real-world data, clinical trial findings, and expert interviews to deliver comprehensive industry intelligence.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Arpit Anand
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=bone-resorption-market-expected-to-grow-significantly-by-2032-market-opportunities-strategic-investments-fda-approvals-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bone Resorption Market Expected to Grow Significantly by 2032: Market Opportunities, Strategic Investments, FDA Approvals | DelveInsight here
News-ID: 4212668 • Views: …
More Releases from ABNewswire

Inflammatory Breast Cancer Market Expected to Experience Substantial Growth by 2 …
The inflammatory breast cancer market is poised for significant growth with a promising pipeline of emerging therapies targeting this rare but aggressive disease. Key breast cancer companies, including Merck, AstraZeneca, Gilead Sciences, Daiichi Sankyo, Pfizer, and several others, are actively developing innovative treatments to address the high unmet needs in inflammatory breast cancer management.
DelveInsight's "Inflammatory Breast Cancer - Market Insight, Epidemiology And Market Forecast [https://www.delveinsight.com/report-store/inflammatory-breast-cancer-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]" report provides an in-depth understanding…

Metastatic HR+/HER2- Breast Cancer Market Projected to Expand Significantly by 2 …
The metastatic HR+/HER2- breast cancer market is experiencing robust growth, fueled by an increasing patient pool and the introduction of innovative targeted therapies. Key breast cancer companies, such as Pfizer, Novartis, AstraZeneca, Roche, Arvinas, Olema Pharmaceuticals, Eli Lilly, and others, are shaping the treatment landscape for this most prevalent subtype of breast cancer.
DelveInsight's "Metastatic HR+/HER2- Breast Cancer Market Insights, Epidemiology, and Market Forecast-2034 [https://www.delveinsight.com/report-store/hr-positive-her2-negative-breast-cancer-market-insights?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]" report provides comprehensive insights into the…

Myelodysplastic Syndrome with Excess Blasts-2 Market Expected to Strengthen Thro …
The MDS-EB2 treatment market is anticipated to witness substantial growth across the 7MM (United States, EU4, United Kingdom, and Japan) by 2032, primarily driven by rising disease awareness, improved diagnostic capabilities, and the development of innovative therapeutic interventions by key MDS-EB2 companies, including Sunesis Pharmaceuticals, Astellas Pharma Global Development Inc., Jazz Pharmaceuticals, Celgene, and Access Pharmaceuticals Inc., among others.
DelveInsight's "Myelodysplastic Syndrome with Excess Blasts2 Market Insight, Epidemiology And Market Forecast…

Schmicko Reveals the 2025 Mobile Car Care Pricing Guide for Sydney Drivers
Image: https://www.abnewswire.com/upload/2025/10/132dbe04bfa5122568ba82ba5f83fd04.jpg
Australia's mobile automotive care market continues to accelerate, driven by demand for convenience, professionalism, and premium vehicle protection. The sector's growth reflects a changing mindset among car owners who now treat car care as an ongoing investment rather than a one-off expense. According to Grand View Research, the Australian car detailing services market-valued at AUD 1,173.6 million in 2022-is projected to reach AUD 2,192.9 million by 2030, growing at…
More Releases for Bone
Bone Densitometers (BDM): Precise Assessment of Bone Health and Osteoporosis Ris …
Bone Densitometers(BDM) Market 2023 Forecast: Unveiling Opportunities and Growth
Bone Densitometers(BDM) Market research report helps to recognize the market challenges and opportunities. Global Bone Densitometers(BDM) Market report contains the recent forecast research for the predicted period. The report extensively offers the latest information about the technological developments and market growth prospect on the basis of the regional landscape. This Report offers a complete evaluation of every area including the volume of…
Demineralized Bone Matrix Market - A Natural Approach to Bone Repair: Deminerali …
Newark, New Castle, USA: The "Demineralized Bone Matrix Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Demineralized Bone Matrix Market: https://www.growthplusreports.com/report/demineralized-bone-matrix-market/7805
This latest report researches the industry structure,…
Bone Glue Market: Rising Adoption of Bone Glue for Orthopedic Surgeries Expected …
The Bone Glue Market is a rapidly growing segment of the medical industry, driven by the increasing prevalence of bone fractures and injuries and the rising demand for effective and reliable bone adhesives. Bone glue, also known as surgical adhesive, is a type of medical adhesive that is used to bond bones together during orthopedic surgeries. The market has been growing steadily for several years, and it is expected to…
Bone Glue Market: Rising Adoption of Bone Glue for Orthopedic Surgeries Expected …
The Bone Glue Market is a rapidly growing segment of the medical industry, driven by the increasing prevalence of bone fractures and injuries and the rising demand for effective and reliable bone adhesives. Bone glue, also known as surgical adhesive, is a type of medical adhesive that is used to bond bones together during orthopedic surgeries. The market has been growing steadily for several years, and it is expected to…
Bone Glue Market: Rising Adoption of Bone Glue for Orthopedic Surgeries Expected …
The Bone Glue Market is a rapidly growing segment of the medical industry, driven by the increasing prevalence of bone fractures and injuries and the rising demand for effective and reliable bone adhesives. Bone glue, also known as surgical adhesive, is a type of medical adhesive that is used to bond bones together during orthopedic surgeries. The market has been growing steadily for several years, and it is expected to…
Bone Graft Substitute Market Report 2018: Segmentation by Type (autograft, demin …
Global Bone Graft Substitute market research report provides company profile for ACE Surgical Supply Company, Inc., BioHorizons IPH, Inc., Dentium Co., Ltd., Dentsply Sirona, Institut Straumann AG, Medtronic plc, Stryker Corporation, Zimmer Biomet and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and…